Cory Scrivner Email & Phone Number

Los Angeles, Ca, Us

California, United States

Alimera Sciences purchased YUTIQ from EyePointResponsible for YUTIQ and ILUVIEN sales and physician training.YUTIQ is a buy and bill injectable pharmaceutical device for the rare disease chronic non-infectious posterior segment uveitis.ILUVIEN is a buy and bill injectable pharmaceutical device for the treatment of Diabetic Macular Edema (DME).

Southern California/Hawaii

• YUTIQ is an injectable device for Chronic, non-infectious posterior segment Uveitis.• Buy & Bill, Injectable• Work with Academic Institutions to train Retina residents through Wet Lab demonstrations.• Train Retina Specialists on the injector and advising during first injections.• 300% growth Q1 2023 v Q1 2022• 151% to quota Q1 2023

Ventura, California

• Launched both Inveltys 1% (post-surgical steroid) 2019 and Eysuvis 0.25% (dry eye steroid) 2020• Mauna Kea Club (Presidents Club) winner 2021• “Hold The Rope” Award winner 2021. Recognition for helping colleagues reach their potential.• 2020 Ranked #19 Nationally during COVID shutdown for Eysuvis and Invites• 2019 Ranked #16 Nationally at 114.4% goal attainment for Inveltys.• Currently ranked #15 nationally for• Instrumental in the addition of Inveltys to CenCal (regional state Medicaid)• Helped choose Physician advocate who successfully presented Eysuvis to Medical Rx( CA StateMedicaid).• Chosen two time Field Input Team Member. This team i stand selected nationally to offer feedbackto Marketing and Upper Level Management. Our feedback helped to alter Marketing messages aswell as internal company processes• Assumed both Trainer and Mentor rolls for new team members in the Los Angeles Region.• Drove most patients to our Medicare Pull Thru Hub during launch of Inveltys 2019

Santa Barbara, California Area

• Launched Xiidra in the Dry Eye space.• Finished #14/122 Nationally at 305% to goal. Goal TRx 336 Actual TRx 1028• Finished 2016 with 31% Xiidra NRx Market Share 48% Xiidra TRx Market Share• Currently Ranked #9 Nationally with Top 10 Xiidra TRx Market Share of 37%• Marketing Brand Team Lead• Regional Training Lead

Ventura/Santa Barbara, Ca

• Peer Leadership Award• Quarter 3 2015 118% to goal for Allergy portfolio.• Quarter 1 2015 nationally ranked #6• 2014 Grew Lotemax Gel (steroid) from 5.72% to 10.04% in 3 quarters.• 2014 3rd national contest winner for Zylet (steroid/antibiotic combination) growth.• 2014 Maintained and met all goals for Besivance (antibiotic).• Looked to as technical district team leader.• Sales responsibility for the following products: Lotemax Gel (steroid), Prolensa (NSAID), Besivance(antibiotic), Lacrisert (dry eye), Zylet (steroid/antibiotic combination), Bepreve (allergy), Alrex(allergy)• Representative Advisory Panel member

Ventura/Santa Barbara, Ca

• Finished 2012 Top 10 Sales Performances – Vice Presidents Circle of Excellence Award Winner.• 2.5 year Member of the Ophthalmics Brand Business Team (1 of 10 members nationallyrepresenting Field Sales’ needs and ideas to Marketing for Glaucoma Sales.• National Leader/Trainer in Managed Care pull through tactics.• Looked to as district team leader.• Recognized as the Team Technical Mentor.• 1 of 10 members of the Rep Advisory Panel for Marketing feedback and advice for new products.• Consistently finished in top 30% for AzaSite sales goals and ranking.• Observed many surgical cases both out patient and in the O.R. (cataract, blepharoplasty, LASIK,LASEK, PRK, keratoplasty, AMD injections).• Launched Zioptan and Cosopt PF in the Glaucoma space.

Ventura/Santa Barbara, Ca

• Recognized as the Team Technical Mentor.• 1 of 10 members of the Rep Advisory Panel for Marketing feedback and advice for new products.• Consistently finished in top 30% for AzaSite sales goals and ranking.• Observed many surgical cases both out patient and in the O.R. (cataract, blepharoplasty, LASIK, LASEK, PRK, keratoplasty, AMD injections).

Irvine, Ca

• Tri I ’07 growth for 1st position product Restasis is three times that of the nation.• Earned Leadership Trip for YTD performance in 2004, 2005.• Trained multiple Surgical new hires in 2006, 2007. Looked to as a team mentor for beginning sales representatives for sales strategies, and technical knowledge.• Team mentor/leader for N. California area for one year period (2006) while having no immediate Area Management. • Three sales promotions since working with Allergan.• Involved in the successful launch of 3 separate products in 2 years, Zymar, Restasis, & Acular LS.• Started in territory ranked 78/98, and moved 63 rankings to finish to year 2003 at 15/98.• Responsible for growing and maintaining market share for Therapeutic Sales Organization. This includes: outside sales, contract negotiations, business consulting, and entertaining.• Work closely with Allergan’s Eye Care Business Advisor Group to bring value-added resources to select clients in order to partner and drive market growth.• Recruited Physician Advocates for speaking on behalf of Allergan products at the Regional and National level. Also, arranged community educational events for physicians to drive market share growth.• Attended numerous surgical preceptorships to gain further knowledge on product performance.• Earned Allergan’s Top Sales Training Excellence Award.